Evolus

Evolus PEG

PEG Ratio (Price/Earnings-to-Growth) of Evolus (EOLS) as of Oct 12, 2026.

PEG

-

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Evolus is 2026 - . PEG Ratio (Price/Earnings-to-Growth) of Evolus was 2025 -0.38 . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Evolus Stock analysis

What does Evolus do? Evolus Inc is an innovative biotechnology company based in Irvine, California, specializing in the development and distribution of aesthetic treatments. The company was founded in 2012 and has quickly become a market leader in the industry. Evolus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Evolus stock

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Evolus since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Evolus with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Evolus

All Key Metrics — Evolus